Article Versions Notes

Zhou J-G, Liang B, Liu J-G, Jin S-H, He S-S, Frey B, Gu N, Fietkau R, Hecht M, Ma H, et al. Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells. 2021; 10(5):977. https://doi.org/10.3390/cells10050977

Zhou, Jian-Guo, Bo Liang, Jian-Guo Liu, Su-Han Jin, Si-Si He, Benjamin Frey, Ning Gu, Rainer Fietkau, Markus Hecht, Hu Ma, and et al. 2021. "Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy" Cells 10, no. 5: 977. https://doi.org/10.3390/cells10050977

Zhou, J.-G., Liang, B., Liu, J.-G., Jin, S.-H., He, S.-S., Frey, B., Gu, N., Fietkau, R., Hecht, M., Ma, H., & Gaipl, U. S. (2021). Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells, 10(5), 977. https://doi.org/10.3390/cells10050977